US Patent Issued to UNIVERSITY OF MARYLAND, BALTIMORE on Aug. 12 for "Yeast-based immunotherapy against Clostridium difficile infection" (Maryland Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,833, issued on Aug. 12, was assigned to UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore).

"Yeast-based immunotherapy against Clostridium difficile infection" was invented by Hanping Feng (Ellicott City, Md.), James Eugene Galen (Eldersburg, Md.), Kevin Chen (Baltimore) and Yixuan Zhu (Ellicott City, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody-based binding agents derived from human and camelid immunoglobulins are described, as well as strains of yeast engineered to secrete the binding agents, and methods of treating and preventing Clostridium difficile infections using the engineered strains of yeast. These binding agents recognize and ...